A recent study led by researchers in the division of cardiovascular medicine at the University of Florida Colle of Medicine entitled “Circulating fibrocyte levels correlate with infarct size in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention” was accepted by the American Heart Journal for publication. The study was completed in conjunction with the division of cardiovascular medicine at the University of Virginia School of Medicine.
In the study, it was found that circulating fibrocyte levels positively correlate with infarct size at 6 months in STEMI patients treated with primary PCI and that these levels may be used as a biomarker of infarct size, if validated in a larger study. Additionally, the changes in circulating fibrocyte levels could potentially be used to assess the response to therapy. Read the full article here.
Congratulations to Dr. Ellen Keeley, Dr. Mohammed Elzeneini, Dr. Mohammad Al-Ani for their work on this study. In addition, thank you to Dr. Borna Mehrad and Ning Yang in the division of pulmonary, critical care and sleep medicine at the University of Florida College of Medicine for their collaboration with our division.
Juan M. Aranda, Jr., MD, FACC, FHFSA
Professor and Chief, Division of Cardiovascular Medicine
Vice Chair of Clinical Affairs, Department of Medicine
University of Florida College of Medicine